How can we achieve WHO's elimination target for hepatitis C incidence?

Affiliations

¹ Odense University Hospital, 5000 Odense C, Denmark. Electronic address: anne.oevrehus@rsyd.dk.
² Department of Gastroenterology, Oslo University Hospital, Norway.

Comment

Anne Lindebo Holm Øvrehus et al. Lancet Gastroenterol Hepatol. 2019 Jun.

. 2019 Jun;4(6):415-417.

doi: 10.1016/S2468-1253(19)30120-7. Epub 2019 Apr 10.

¹ Odense University Hospital, 5000 Odense C, Denmark. Electronic address: anne.oevrehus@rsyd.dk.
² Department of Gastroenterology, Oslo University Hospital, Norway.

No abstract available

Comment on

The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.
Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, Hickman M, Degenhardt L, May MT, Vickerman P. Trickey A, et al. Lancet Gastroenterol Hepatol. 2019 Jun;4(6):435-444. doi: 10.1016/S2468-1253(19)30085-8. Epub 2019 Apr 10. Lancet Gastroenterol Hepatol. 2019. PMID: 30981685 Free PMC article.